Clinical Trial Update: A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Heart Failure [Phase 3]

View source ↗

Summary

A Phase 3 trial update for Extended-Release Carvedilol Sulfate in heart failure, with current status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Extended-Release Carvedilol Sulfate (carvedilol sulfate)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Heart Failure | Phase 3 | Status: UNKNOWN